// COMPANY
TRex Bio
SECTOR BIOTECHMENTIONS 4LAST SEEN OCTOBER 13, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
4 SIGNALS
01
funding·Axios Pro Rata·OCTOBER 13, 2026
“TRex Bio priced at the low end of its $14-$16 range”
02
03
funding·PitchBook News·OCTOBER 6, 2026
“Autoimmune and inflammatory disease-focused biotech TRex Bio, which is backed by Eli Lilly, is seeking to raise about $133.3 million in its IPO.”
Source→04
funding·Axios Pro Rata·OCTOBER 5, 2026
“TRex has raised over $220m from firms like Eli Lilly (which is buying back in via the IPO)...”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.